These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19025747)

  • 1. Self-assembly of antibodies by chemical induction.
    Li Q; Hapka D; Chen H; Vallera DA; Wagner CR
    Angew Chem Int Ed Engl; 2008; 47(52):10179-82. PubMed ID: 19025747
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of recombinant scFv-antibodies against diphtheria toxin using phage display system].
    Oleĭnik ES; Kaberniuk AA; Burkaleva DA; Romaniuk SI; Kolibo DV; Shepeliakovskaia AO; Laman AG; Komisarenko SV
    Ukr Biokhim Zh (1999); 2007; 79(5):91-7. PubMed ID: 18357781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of monoclonal antibody engineering.
    Renner C; Hartmann F; Pfreundschuh M
    Ann Hematol; 2001; 80 Suppl 3():B127-9. PubMed ID: 11757694
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemically self-assembled antibody nanostructures as potential drug carriers.
    Fegan A; Kumarapperuma SC; Wagner CR
    Mol Pharm; 2012 Nov; 9(11):3218-27. PubMed ID: 23013206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural correspondences between mouse and human immunoglobulin VH genes. Application to the humanization of mouse monoclonal antibodies.
    Poul MA; Lefranc MP
    Ann N Y Acad Sci; 1995 Sep; 764():359-61. PubMed ID: 7486546
    [No Abstract]   [Full Text] [Related]  

  • 6. Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody.
    Arakawa F; Kuroki M; Kuwahara M; Senba T; Ozaki H; Matsuoka Y; Misumi Y; Kanda H; Watanabe T
    J Biochem; 1996 Sep; 120(3):657-62. PubMed ID: 8902633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP; Crowe JS
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract]   [Full Text] [Related]  

  • 8. Programmable self-assembly of antibody-oligonucleotide conjugates as small molecule and protein carriers.
    Gangar A; Fegan A; Kumarapperuma SC; Wagner CR
    J Am Chem Soc; 2012 Feb; 134(6):2895-7. PubMed ID: 22296405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
    Yang X; Hu W; Li F; Xia H; Zhang Z
    Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
    Neshat MN; Goodglick L; Lim K; Braun J
    Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.
    Krauss J; Arndt MA; Vu BK; Newton DL; Seeber S; Rybak SM
    Biochem Biophys Res Commun; 2005 Jun; 331(2):595-602. PubMed ID: 15850802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically induced self-assembly of enzyme nanorings.
    White BR; Li Q; Wagner CR
    Methods Mol Biol; 2011; 743():17-26. PubMed ID: 21553179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced protein dimerization in vivo through covalent labeling.
    Gendreizig S; Kindermann M; Johnsson K
    J Am Chem Soc; 2003 Dec; 125(49):14970-1. PubMed ID: 14653715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.
    Caldas C; Coelho V; Kalil J; Moro AM; Maranhão AQ; Brígido MM
    Mol Immunol; 2003 May; 39(15):941-52. PubMed ID: 12695120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.
    Nikula TK; Bocchia M; Curcio MJ; Sgouros G; Ma Y; Finn RD; Scheinberg DA
    Mol Immunol; 1995 Aug; 32(12):865-72. PubMed ID: 7565813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
    Dey B; Del Castillo CS; Berger EA
    J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.
    Furuta M; Uchikawa M; Ueda Y; Yabe T; Taima T; Tsumoto K; Kojima S; Juji T; Kumagai I
    Protein Eng; 1998 Mar; 11(3):233-41. PubMed ID: 9613848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs.
    Mössner E; Koch H; Plückthun A
    J Mol Biol; 2001 Apr; 308(2):115-22. PubMed ID: 11327756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope analysis and primary structures of variable regions of anti-human FcepsilonRI monoclonal antibodies, and expression of the chimeric antibodies fused with human constant regions.
    Takai T; Yuuki T; Iwamoto-Yasue N; Okumura K; Ra C
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1856-67. PubMed ID: 11055388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.